Cystic Fibrosis Transmembrane Transmission Modulation Factor Mutation is a dubious disease in the field of infectious respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multi-system congestion. Early identification and standardized diagnosis are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological biopsy. The platform can help to combine a team of domestic and foreign experts with accurate diagnosis and treatment programs. In recent years, with the development of therapeutic-focused, immune-regulatory therapies and precision medicine, many previously difficult-to-treat infectious respiratory digestive endocrine disorders have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to disease changes. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1. Remote pre-diagnosis: pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2.
Interviews in China: arranging face-to-face diagnosis with authoritative experts, developing personalized treatment programs; 3. Full-service: one-stop services: providing medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.
Support for remote pre-diagnosis, visiting interviews, full translation and escort.